These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7637658)

  • 1. Moexipril: another ACE inhibitor for hypertension.
    Med Lett Drugs Ther; 1995 Sep; 37(956):75-6. PubMed ID: 7637658
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of the new angiotensin-converting enzyme inhibitor moexipril on the circadian rhythms of arterial pressure in hypertension patients].
    Ol'binskaia LI; Andrushchishina TB
    Ter Arkh; 1997; 69(3):58-61. PubMed ID: 9229835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decreasing blood pressure and more: ACE inhibitor in coronary heart disease?].
    MMW Fortschr Med; 2000 Oct; 142(42):50-1. PubMed ID: 11077829
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinapril for hypertension.
    Med Lett Drugs Ther; 1992 Mar; 34(866):27-8. PubMed ID: 1542279
    [No Abstract]   [Full Text] [Related]  

  • 5. Moexipril. A review of its use in the management of essential hypertension.
    Brogden RN; Wiseman LR
    Drugs; 1998 Jun; 55(6):845-60. PubMed ID: 9617599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB; Stimpel M
    J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause.
    Agabiti-Rosei E; Ambrosioni E; Pirelli A; Stimpel M; Zanchetti A
    Eur J Clin Pharmacol; 1999 May; 55(3):185-9. PubMed ID: 10379633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of moexipril, a new ACE inhibitor, as add-on therapy to nifedipine in patients with essential hypertension.
    Persson B; Widgren BR; Fox A; Stimpel M
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):73-8. PubMed ID: 7564369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors: review of four new agents.
    Binder SB
    Am Fam Physician; 1993 Oct; 48(5):851-7. PubMed ID: 8213415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of moexipril in the treatment of hypertension.
    White WB; Fox AA; Stimpel M
    J Hum Hypertens; 1994 Dec; 8(12):917-21. PubMed ID: 7884791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M; Koch B; Jansen T; Fox A; Loh I
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):769-73. PubMed ID: 8961074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats.
    Stimpel M; Jee WS; Ma Y; Yamamoto N; Chen Y
    J Hypertens; 1995 Dec; 13(12 Pt 2):1852-6. PubMed ID: 8903666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG; Fox AA; Stimpel M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertensive patients with signs of coronary heart disease. An ACE inhibitor improves endothelial function].
    MMW Fortschr Med; 2001 Aug; 143(33-34):58-9. PubMed ID: 11561465
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors and the otolaryngologist.
    Cruickshank HE
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):189-91. PubMed ID: 7554324
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.
    Asmar R; Sayegh F; Tracz W; Hlawaty M; Olszowska M; Jourde M; Vincent M; Goujoun B; Maldonado J
    Acta Cardiol; 2002 Feb; 57(1):31-2. PubMed ID: 11918132
    [No Abstract]   [Full Text] [Related]  

  • 19. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile and clinical use of moexipril.
    Chrysant SG; Chrysant GS
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):345-52. PubMed ID: 15030263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.